Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer – An NRG/GOG study-Reference-Cited by-同舟云学术

Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer – An NRG/GOG study

Published:2024-02 Issue: Volume:181 Page:54-59
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Chan John K.,Tian Chunqiao,Kesterson Joshua P.,Lin Ken Y.,Darcy Kathleen,Richardson Michael T.,Kapp Daniel S.,Monk Bradley J.,McNally Leah,Landrum Lisa,Copeland Larry,Walker Joan L.,Wenham Robert M.,Phippen Neil,Spirtos Nick M.,Tewari Krishnansu,Shahin Mark,Berry Laurel,Bell Jeffery G.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference26 articles.

1. Cancer statistics, 2023;Siegel;CA Cancer J. Clin.,2023

2. SEER Cancer Stat Facts: Ovarian Cancer. National Cancer Institute. Bethesda, M., https://seer.cancer.gov/statfacts/html/ovary.html.

3. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study;Young;J. Clin. Oncol.,2003

4. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials;Young;N. Engl. J. Med.,1990

5. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a gynecologic oncology group study;Bell;Gynecol. Oncol.,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostischer Wert von CA-125 bei Hochrisiko-Ovarialkarzinom im Frühstadium;Frauenheilkunde up2date;2024-08

2. Prognostischer Wert von CA-125 bei Hochrisiko-Ovarialkarzinom im Frühstadium;TumorDiagnostik & Therapie;2024-05-28

3. Prognostischer Wert von CA-125 bei Hochrisiko-Ovarialkarzinom im Frühstadium;Geburtshilfe und Frauenheilkunde;2024-04